Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cells|November 13, 2025
Cancer-Associated Fibroblasts Move and Interact More with Triple-Negative Breast Cancer Cells and Stimulate Their Proliferation in a Hyaluronan-Dependent MannerSz-Ying Hou, Sarah C Macfarlane, Ariadna Gómez Torijano, et al.
Cancers|April 3, 2021
Osteoblast-Derived Paracrine and Juxtacrine Signals Protect Disseminated Breast Cancer Cells from StressRussell Hughes, Xinyue Chen, Natasha Cowley, et al.
Cancers|October 14, 2022
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone MetastasisJiabao Zhou, Jennifer M Down, Christopher N George, et al.
JBMR Plus|September 22, 2025
ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical modelsDiane V Lefley, Callum G Jones, Jiabao Zhou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2015
Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancerNing Wang, Freyja Docherty, Hannah K Brown, et al.
Cancer Letters|February 22, 2019
Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancerRyan T Bishop, Silvia Marino, Daniëlle de Ridder, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerNing Wang, Kimberley J Reeves, Hannah K Brown, et al.
Bone Reports|August 26, 2024
Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse modelMai Morita, Fawaz Arshad, Lewis A Quayle, et al.
Oncogene|February 2, 2020
A role for CBFβ in maintaining the metastatic phenotype of breast cancer cellsRan Ran, Hannah Harrison, Nur Syamimi Ariffin, et al.
Cancer Letters|June 1, 2020
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysisRyan T Bishop, Silvia Marino, Giovana Carrasco, et al.
Pageof 7